Hostname: page-component-7b7567c8c-tnkh4 Total loading time: 0 Render date: 2026-11-18T00:51:45.991Z Has data issue: false hasContentIssue false

A Controlled Trial of Reserpine in Chronic Schizophrenia

Published online by Cambridge University Press:  08 February 2018

E. S. Goller*
Affiliation:
St. Bartholomew's Hospital, London
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Since the introduction of reserpine by Kline in 1954 there have been relatively few studies of its use in schizophrenia and most of these have been uncontrolled. It is characteristic of these uncontrolled trials that when the results are assessed, they are described in glowing terms, and the percentage of patients reported as showing “moderate” or “marked” improvement is high.

Information

Type
Original Articles
Copyright
Copyright © Royal College of Psychiatrists, 1960 
Submit a response

eLetters

No eLetters have been published for this article.